411 related articles for article (PubMed ID: 35659313)
1. EQ-5D-Y-3L and EQ-5D-Y-5L proxy report: psychometric performance and agreement with self-report.
Fitriana TS; Purba FD; Stolk E; Busschbach JJV
Health Qual Life Outcomes; 2022 Jun; 20(1):88. PubMed ID: 35659313
[TBL] [Abstract][Full Text] [Related]
2. Psychometric Performance Comparison of the Adapted versus Original Versions of the EQ-5D-Y-3L and -Y-5L in Proxy Respondents for 2- to 4-Year-Olds.
van Heusden A; Rivero-Arias O; Herdman M; Hiscock H; Devlin N; Dalziel K;
Pharmacoeconomics; 2024 Jun; 42(Suppl 1):129-145. PubMed ID: 38238604
[TBL] [Abstract][Full Text] [Related]
3. Comparing measurement properties of EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients.
Fitriana TS; Purba FD; Rahmatika R; Muhaimin R; Sari NM; Bonsel G; Stolk E; Busschbach JJV
Health Qual Life Outcomes; 2021 Nov; 19(1):256. PubMed ID: 34781978
[TBL] [Abstract][Full Text] [Related]
4. A Comparison of the Psychometric Properties of the EQ-5D-Y-3L and EQ-5D-Y-5L Using Paediatric Multi-Instrument Comparison (P-MIC) Study Data.
Bahrampour M; Devlin N; Jones R; Dalziel K; Mulhern B;
Pharmacoeconomics; 2024 Jun; 42(Suppl 1):95-111. PubMed ID: 38748193
[TBL] [Abstract][Full Text] [Related]
5. Psychometric performance of proxy-reported EQ-5D youth version 5-level (EQ-5D-Y-5L) in comparison with three-level (EQ-5D-Y-3L) in children and adolescents with scoliosis.
Lin J; Wong CKH; Cheung JPY; Cheung PWH; Luo N
Eur J Health Econ; 2022 Nov; 23(8):1383-1395. PubMed ID: 35122171
[TBL] [Abstract][Full Text] [Related]
6. Patient-caregiver agreement and test-retest reliability of the EQ-5D-Y-3L and EQ-5D-Y-5L in paediatric patients with haematological malignancies.
Zhou W; Shen A; Yang Z; Wang P; Wu B; Herdman M; Luo N
Eur J Health Econ; 2021 Sep; 22(7):1103-1113. PubMed ID: 33950465
[TBL] [Abstract][Full Text] [Related]
7. Comparing the psychometric properties of EQ-5D-3L and EQ-5D-5L proxy ratings by informal caregivers and a health professional for people with dementia.
Michalowsky B; Hoffmann W; Mohr W; Rädke A; Xie F
Health Qual Life Outcomes; 2022 Oct; 20(1):140. PubMed ID: 36199138
[TBL] [Abstract][Full Text] [Related]
8. Psychometric performance of the Chichewa versions of the EQ-5D-Y-3L and EQ-5D-Y-5L among healthy and sick children and adolescents in Malawi.
Ngwira LG; Maheswaran H; Verstraete J; Petrou S; Niessen L; Smith SC
J Patient Rep Outcomes; 2023 Mar; 7(1):22. PubMed ID: 36892714
[TBL] [Abstract][Full Text] [Related]
9. Investigating the psychometric properties of the EQ-5D-Y-3L, EQ-5D-Y-5L, CHU-9D, and PedsQL in children and adolescents with osteogenesis imperfecta.
Xu RH; Zhu L; Sun R; Tan RL; Luo N; Zou S; Dong D
Eur J Pediatr; 2022 Dec; 181(12):4049-4058. PubMed ID: 36156120
[TBL] [Abstract][Full Text] [Related]
10. Comparative Psychometric Performance of Common Generic Paediatric Health-Related Quality of Life Instrument Descriptive Systems: Results from the Australian Paediatric Multi-Instrument Comparison Study.
Jones R; O'Loughlin R; Xiong X; Bahrampour M; Devlin N; Hiscock H; Chen G; Mulhern B; Dalziel K;
Pharmacoeconomics; 2024 Jun; 42(Suppl 1):39-55. PubMed ID: 37955799
[TBL] [Abstract][Full Text] [Related]
11. An Investigation of Inter-Rater and Intra-Proxy Agreement in Measuring Quality of Life of Children in the Community Using the EQ-5D-Y-3L.
Khanna D; Khadka J; Mpundu-Kaambwa C; Chen G; Dalziel K; Devlin N; Ratcliffe J;
Pharmacoeconomics; 2024 Jun; 42(Suppl 1):113-128. PubMed ID: 38280125
[TBL] [Abstract][Full Text] [Related]
12. Comparing the Psychometric Performance of Generic Paediatric Health-Related Quality of Life Instruments in Children and Adolescents with ADHD, Anxiety and/or Depression.
O'Loughlin R; Jones R; Chen G; Mulhern B; Hiscock H; Devlin N; Dalziel K;
Pharmacoeconomics; 2024 Jun; 42(Suppl 1):57-77. PubMed ID: 38329689
[TBL] [Abstract][Full Text] [Related]
13. Measurement properties and responsiveness of the EQ-5D-Y-5L compared to the EQ-5D-Y-3L in children and adolescents receiving acute orthopaedic care.
Verstraete J; Marthinus Z; Dix-Peek S; Scott D
Health Qual Life Outcomes; 2022 Feb; 20(1):28. PubMed ID: 35177084
[TBL] [Abstract][Full Text] [Related]
14. Fighting to Breathe and Fighting for Health-Related Quality of Life: Measuring the Impact of Being Dependent on Technology for Breathing on the Child and Their Caregiver.
Verstraete J; Booth C; Booth J; Peer S; McGuire J; Kritzinger F; Gray T; Zibi N; Shabangu P; Zampoli M
Patient; 2024 Jan; 17(1):65-82. PubMed ID: 37991685
[TBL] [Abstract][Full Text] [Related]
15. Comparing Measurement Properties of the English EQ-5D-Y 3-Level Version With the 5-Level Version in South Africa.
Verstraete J; Amien R; Scott D
Value Health Reg Issues; 2022 Jul; 30():140-147. PubMed ID: 35429927
[TBL] [Abstract][Full Text] [Related]
16. Testing measurement properties of two EQ-5D youth versions and KIDSCREEN-10 in China.
Pei W; Yue S; Zhi-Hao Y; Ruo-Yu Z; Bin W; Nan L
Eur J Health Econ; 2021 Sep; 22(7):1083-1093. PubMed ID: 33893889
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of Proxy-Reported EQ-5D-3L-Y and Its Agreement in Self-reported EQ-5D-3L-Y for Patients With Adolescent Idiopathic Scoliosis.
Lin J; Wong CKH; Cheung PWH; Luo N; Cheung JPY
Spine (Phila Pa 1976); 2020 Jul; 45(13):E799-E807. PubMed ID: 32539293
[TBL] [Abstract][Full Text] [Related]
18. Validity and responsiveness of EQ-5D-Y in children with haematological malignancies and their caregivers.
Zhou W; Shen A; Yang Z; Wang P; Wu B; Herdman M; Busschbach J; Luo N
Eur J Health Econ; 2024 Feb; ():. PubMed ID: 38356007
[TBL] [Abstract][Full Text] [Related]
19. Psychometric Properties of the Spanish Versions of EQ-5D-Y-3L and EQ-5D-Y-5L in Children with Cancer: A Comparative Study.
Perez-Sousa MA; Olivares PR; Gusi N
Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141694
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Psychometric Properties of the EQ-5D-3L-Y and EQ-5D-5L-Y Instruments in Spanish Children and Adolescents.
Pérez-Sousa MÁ; Olivares PR; Ramírez-Vélez R; Gusi N
Value Health; 2021 Dec; 24(12):1799-1806. PubMed ID: 34838278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]